AAAAAA

   
Results: 1-7 |
Results: 7
SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE
Authors: RICHARD IH KURLAN R TANNER C FACTOR S HUBBLE J SUCHOWERSKY O WATERS C GOETZ C JUNCOS JL STERN M HARRISON MB SETHI KD STANDAERT D TROSCH R REICH S KIEBURTZ K FEIGIN A MARSHALL FJ GAUTHIER S PANISSET M LEW ME FRIEDMAN JH PAULSON G RODNITZKY RL HAUSER R KURTH M HURTIG H THAL L ELMER LW PERLMUTTER JS GOLBE LI COMELLA C LANG A MARK MH SINGER C SHOULSON I WEINER WJ PFEIFFER R MAREK KL NUTT J WOOTEN GF JANKOVIC J LEWITT P HOEHN M BENNETT J PARSA M KOLLER W
Citation: Ih. Richard et al., SEROTONIN SYNDROME AND THE COMBINED USE OF DEPRENYL AND AN ANTIDEPRESSANT IN PARKINSONS-DISEASE, Neurology, 48(4), 1997, pp. 1070-1077
IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA
Authors: SHOULSON I FAHN S OAKES D LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K KOLLER W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K SUCHOWERSKY O BRIN MF BRESSMAN SB WEINER WJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K BAKER D CASACELI C EBERLY S MCDERMOTT M NOBEL R ORME C PELUSIO RM PLUMB S RUDOLPH A RANDOLPH H SOTACK J WATTS A
Citation: I. Shoulson et al., IMPACT OF DEPRENYL AND TOCOPHEROL TREATMENT ON PARKINSONS-DISEASE IN DATATOP SUBJECTS NOT REQUIRING LEVODOPA, Annals of neurology, 39(1), 1996, pp. 29-36
INTENSIVE SPEECH TREATMENT FOR PATIENTS WITH PARKINSONS-DISEASE - SHORT-TERM AND LONG-TERM COMPARISON OF 2 TECHNIQUES
Authors: RAMIG LO COUNTRYMAN S OBRIEN C HOEHN M THOMPSON L
Citation: Lo. Ramig et al., INTENSIVE SPEECH TREATMENT FOR PATIENTS WITH PARKINSONS-DISEASE - SHORT-TERM AND LONG-TERM COMPARISON OF 2 TECHNIQUES, Neurology, 47(6), 1996, pp. 1496-1504
EFFICACY OF SPEECH TREATMENT FOR PARKINSONS-DISEASE - 2-YEAR FOLLOW-WP
Authors: RAMIG L COUNTRYMAN S OBRIEN C HOEHN M THOMPSON L
Citation: L. Ramig et al., EFFICACY OF SPEECH TREATMENT FOR PARKINSONS-DISEASE - 2-YEAR FOLLOW-WP, Neurology, 46(2), 1996, pp. 5116-5116
TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS
Authors: KURTH MC ADLER CH STHILAIRE M SINGER C WATERS C CHERNIK DA DORFLINGER E YOO K DAVIS T HOEHN M LEWITT P MONTGOMERY E MUENTER M TANNER C TRUGMAN J
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-276
CEREBROSPINAL-FLUID HOMOVANILLIC-ACID IN THE DATATOP STUDY ON PARKINSONS-DISEASE
Authors: SHOULSON I FAHN S OAKES D ODOROFF C LANG A LANGSTON JW LEWITT P OLANOW CW PENNEY JB TANNER C KIEBURTZ K RUDOLPH A PELUSIO RM KOLLER W OLANOW W RODNITZKY R FINK JS GROWDON JH PAULSON G KURLAN R FRIEDMAN JH GANCHER S NUTT J RAJPUT AH BENNETT JB WOOTEN GF GOETZ C SHANNON K BRIN MF BRESSMAN SB WEINER MJ SANCHEZRAMOS J JANKOVIC J HOEHN M TETRUD J GRIMES JD PFEIFFER R SHULTS C THAL L GAUTHIER S GOLBE LI PERLMUTTER JS MOSES H REICH SG HURTIG HI STERN M BARTER R VETEREOVERFIELD B GAUGER L MALAPIRA T DOBSON J ATAMIAN S TENNIS M COHEN JB DESCLOS G HOFFMAN E DENIO L HUBER S WOIKE T ZOOG K MENDELL R DUDTE K BEHR J GARDINER IF LANNON M CARTER J NORTHRUP S KANIGAN B TURK M LANDOW E SCHLICK P MISTURA K CARROLL VS THELEN JA DEMONG C WINFIELD L MOSKOWITZ C INGENITO A SHELDON C CORNELIUS L HEIBERG D DUNNE C BRADY J KIERANS C BELLESCANTLEBURY L DUFF J WEBER H SAVOINI D LEWIS P KUTNER SJ GRAY P GLAESKE C HOFMAN R PAY MM SALMON D MCFAUL F AMYOT D BERGEN M MCGEEMINNICH L ODONNELL P FERRISE S SHALLOW K
Citation: I. Shoulson et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID IN THE DATATOP STUDY ON PARKINSONS-DISEASE, Archives of neurology, 52(3), 1995, pp. 237-245
A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE
Authors: OLANOW CW FAHN S MUENTER M KLAWANS H HURTIG H STERN M SHOULSON I KURLAN R GRIMES JD JANKOVIC J HOEHN M MARKHAM CH DUVOISIN R REINMUTH O LEONARD HA AHLSKOG E FELDMAN R HERSHEY L YAHR MD
Citation: Cw. Olanow et al., A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PERGOLIDE AS AN ADJUNCT TO SINEMET(R) IN PARKINSONS-DISEASE, Movement disorders, 9(1), 1994, pp. 40-47
Risultati: 1-7 |